Series C funding round for Amolyt Pharma raising $140M in January 2023
Series C funding round for Amolyt Pharma raising $140M in January 2023
| Investor | Firm Type | Partner |
|---|
ICGLEAD | Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Public | — |
| Venture Capital | — |
| Angel | Vincent Brichard |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$305.5M
Top Valuation
-
Amolyt Pharma raised $140M in a Series C round.
The round was announced on 01/01/23.
The round was led by Toby Sykes, Cédric Moreau.